Status:
RECRUITING
Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Scleroderma Foundation
Conditions:
Scleroderma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The stu...
Eligibility Criteria
Inclusion
- Have physician-diagnosis of Systemic sclerosis (SSc) (any subtype)
- A score of ≥ 10 on the Perceived Deficits Questionnaire
- A score of ≤ 7 on the 6-Item Cognitive Impairment Test
- Have access to a reliable, internet-connected device (e.g. computer, smartphone, tablet)
- Visual acuity with correction sufficient to work on a computer, smartphone, tablet or screen
- Be able to read, speak, and understand English
Exclusion
- Diagnosis of dementia or head injury
- Other neurological disorders that might impact cognition
- Have major psychiatric disorder such as major depression and schizophrenia
- Complex, unstable health issues that would preclude full participation in the study (like a planned surgery or active cancer treatment)
Key Trial Info
Start Date :
April 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06880627
Start Date
April 16 2025
End Date
June 1 2027
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109